Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Treatments haloperidol

CJ-Receptors are localized ia the brain stem and limbic stmcture, regions associated with endocrine function (76). In the periphery, CJ-receptors are found in the Hver, heart, ileum, vas deferens, and on lymphocytes and thymocytes. Although there is insufficient evidence to clearly define the functional role of CNS CJ-sites, based on the effects of PCP and the interaction of haloperidol with CJ-sites, CJ-receptor ligands may be antipsychotics or used for the treatment of substance abuse. Several CJ-receptor ligands have shown neuroprotective effects in vivo. Ifenprodil (315) and CNS 1102 (316) are being developed for treatment of stroke (Table 18). [Pg.574]

In noncancer-related pharmacology, GSK3 is inhibited by lithium at therapeutic concentrations, implying that the long-established effectiveness of lithium in the treatment of psychiatric mood disorders (and more recently as a neuroprotective agent) may be linked to GSK3 inhibition. Antipsychotics such as haloperidol... [Pg.1321]

Haverkos HW, Pinsky PF, Drotman DP, etal Disease manifestation among homosexual men with acquired immunodeficiency syndrome a possible role of nitrites in Kaposi s sarcoma. Sex Transm Dis 12 203-208, 1985 Haverkos HW, Kopstein AN, Wilson H, et al Nitrite inhalants history, epidemiology, and possible links to AIDS. Environ Health Perspect 102 858-861, 1994 Hernandez-Avila CA, Ortega-Soto HA, Jasso A, et al Treatment of inhalant-induced psychotic disorder with carbamazepine versus haloperidol. Psychiatr Serv49 812— 815, 1998... [Pg.307]

Each of the analyses reported outcomes for patients responding to and continuing treatment after the original 6-week clinical trial that is, after the exclusion of patients withdrawing from the original trial for whatever reason (e.g. poor tolerability, lack of response). This probably introduced bias in favour of haloperidol, since there were significantly more responders to olanzapine. [Pg.31]

Almond S, O Donnell O (2000). Cost analysis of the treatment of schizophrenia in the UK a comparison of olanzapine and haloperidol. Pharmacoeconomics 17, 383—9. [Pg.38]

Edgell ET, Hamilton SH, Revicki DA, et al (1998). Costs of olanzapine treatment compared with haloperidol for schizophrenia results from a randomized clinical trial. Poster presented at the 21st CINP Congress, Glasgow, July 1998. [Pg.39]

Grainger DL, Hamilton SH, Genduso LA, et al (1998a). Medical resource use and work and social outcomes for olanzapine compared with haloperidol in the treatment of schizophrenia and other psychotic disorders. Poster presented at the 21st Congress of the CINP, Gla ow, July 1998. [Pg.39]

Tollefson GD, Beasley CM, Tran PV (1997). Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders results of an international collaborative trial. Am J Psychiatry 154, 457-65. [Pg.42]

There is, however, a unique risk in the bipolar form that antidepressant treatment may trigger a switch into mania. This may occur either as the natural outcome of recovery from depression or as a pharmacological effect of the drug. Particular antidepressants (the selective serotonin reuptake inhibitors) seem less liable to induce the switch into mania than other antidepressants or electroconvulsive therapy. Treatment for mania consists initially of antipsychotic medication, for instance the widely used haloperidol, often combined with other less specific sedative medication such as the benzodiazepines (lorazepam intramuscularly or diazepam orally). The manic state will usually begin to subside within hours and this improvement develops further over the next 2 weeks. If the patient remains disturbed with manic symptoms, additional treatment with a mood stabilizer may help. [Pg.71]

Chouinard G, Jones B, Remington G, et al (1993). A Canadian multicentre placebo controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic inpatients./Clin Psychopharmacol25—40. [Pg.97]

Giannini, A.J. Eighan, M.S. Loiselle, R.H. and Giannini, M.C. Comparison of haloperidol and chiorpromazine in the treatment of phencyclidine psychosis. J. Clin Pharmacol 244 202-204, 1984. Grove, V.E. Painless self-injury after ingestion of "angel dust." TAMA 242 655, 1979. [Pg.229]

Conventional antipsychotic drugs such as chlorpromazine and haloperidol have long been used in the treatment of acute mania. More recently, atypical antipsychotic drugs including aripiprazole, olanzapine, quetiapine, risperidone, and ziprasi-done have been approved for the treatment of bipolar mania or mixed mood episodes as monotherapy or in combination with mood-stabilizing drugs.25 Aripiprazole and olanzapine are also approved for maintenance therapy. The combination of olanzapine and fluoxetine is approved for treatment of bipolar depression. Quetiapine is approved for treatment of... [Pg.600]

Zhang, H. Y., Shu, L., Li, H. F. et al. (2006). Risperidone versus haloperidol in treatment of acute manic episodes of bipolar 1 disorder a randomized double-blind controlled multicenter study. Journal of Chinese Psychiatry, 39(1), 33-7. [Pg.96]

Zhou, M., Liu, P., Zhang, H. Y. et al. (2002). Double-blind comparison between risperidone and haloperidol in the treatment of schizophrenic patients. Chinese Journal of Clinical Pharmacology, 18(5), 341. ... [Pg.96]

Opolka etal. (2003) examined Texas Medicaid claims for patients with schizophrenia or schizoaffective disorder during the period of January 1996 to August 1998. These patients had been initiated to treatment with either haloperi-dol or olanzapine and had no previous use of these medications in the year prior (total, n = 2601 haloperidol, n = 726 olanzapine, n = 1875). [Pg.101]

Figure 3 Putative model for the mechanism by which biogenic amines stimulate CE secretion across the rabbit corneal epithelium. Epn = epinephrine Nep = norepinephrine Tim = Timolol Ser = serotonin Msg = methysergide Dop = dopamine Hal = haloperi-dol (E = (E-adrenoceptor AC = adenylate cyclase. The scheme is consistent with the observation that epithelial responsiveness to serotonin and dopamine can be blocked by their receptor antagonists haloperidol and methysergide, respectively, and by both timolol treatment and sympathectomy. The probable source of serotonin or dopamine is the sympathetic fibers that innervate the cornea. (From Ref. 284.)... Figure 3 Putative model for the mechanism by which biogenic amines stimulate CE secretion across the rabbit corneal epithelium. Epn = epinephrine Nep = norepinephrine Tim = Timolol Ser = serotonin Msg = methysergide Dop = dopamine Hal = haloperi-dol (E = (E-adrenoceptor AC = adenylate cyclase. The scheme is consistent with the observation that epithelial responsiveness to serotonin and dopamine can be blocked by their receptor antagonists haloperidol and methysergide, respectively, and by both timolol treatment and sympathectomy. The probable source of serotonin or dopamine is the sympathetic fibers that innervate the cornea. (From Ref. 284.)...

See other pages where Treatments haloperidol is mentioned: [Pg.749]    [Pg.749]    [Pg.250]    [Pg.541]    [Pg.359]    [Pg.323]    [Pg.182]    [Pg.297]    [Pg.302]    [Pg.22]    [Pg.23]    [Pg.91]    [Pg.92]    [Pg.362]    [Pg.81]    [Pg.532]    [Pg.537]    [Pg.538]    [Pg.555]    [Pg.555]    [Pg.555]    [Pg.556]    [Pg.564]    [Pg.28]    [Pg.28]    [Pg.88]    [Pg.92]    [Pg.93]    [Pg.94]    [Pg.135]    [Pg.216]   
See also in sourсe #XX -- [ Pg.213 ]




SEARCH



Haloperidol

© 2024 chempedia.info